MRNA YTD Stock Return Of -27% Outperforms SGEN by 73% and Underperforms SRPT by -66%

Retrieved on: 2024-09-04 15:24:51

Tags for this article:

Click the tags to see associated articles and topics

MRNA YTD Stock Return Of -27% Outperforms SGEN by 73% and Underperforms SRPT by -66%. View article details on hiswai:

Excerpt

Moderna (MRNA) returned -27% YTD; MRNA outperformed Seagen by 73% (SGEN returned -100%). SGEN LTM revenue changed 23% vs.

Article found on: www.trefis.com